MMP7 and acute myeloid leukemia: Despite its implications in AML, research specifically examining MMP7 in blood cancers remains remarkably limited, yet high levels of MMP7 have been associated with increased leukemic cell migration and resistance to apoptosis, suggesting its crucial role in disease progression and highlighting its potential as a therapeutic target [24–26].